Mental Health Advocacy Groups: Contact Details

So this should make steady fat loss devoid fat loss, if you are levelheaded and do not cheat.

This structure says to put a greenish light on for hearty foods and a dark red light on for unhealthy foods.

As such only continue to eat healthy. You may as well consider attempting a high protein/low carbohydrate diet. Actually, it does achieve results, It’s not as healthily balanced as a great healthy eating diet should’ve been. Truly independent patient advocacy groups most probably will be controlled by volunteers who actually take mental health drugs themselves.

Like policies against accepting funding from drug companies, true grassroots patient advocacy groups will have fire walls against donor influence. It’s a well-known fact that the National Alliance on Mental Illness, sometimes mistakenly called the National Alliance for the Mentally Ill, is a organization that describes itself as the nation’s largest grassroots mental health organization dedicated to improving the lives of persons living with serious mental illness and their families. NAMI’s leading donor is Eli Lilly and Company, maker of Prozac, that gave $ 87 million during that period. While According to internal documents obtained by Mother Jones, 18 drug firms gave NAMI a tal of $ 11 dot 72 million between 1996 and midThese include Janssen, Novartis, Pfizer, Abbott Laboratories, Wyeth Ayerst Pharmaceuticals, and Bristol Myers Squibb, moJo wrote. Critics pointed out that NAMI tends to emphasize drug treatments for mental illness, and that pharmaceutical companies tend to shape the group’s agenda. They parrot the line of the drug companies in saying that drugs are the essential thing, said Janet Foner, a co coordinator of Support Coalition International, an activist organization of psychiatric survivors, they appear to be a completely independent organization.

With the lion’s share preparing to hereafter left Lilly and served as NAMI’s paid interim executive director until mid The group acknowledged this once being shown Radke’s resume listing the job. While stating that The National Alliance on Mental Illness, an outspoken patient advocate, lobbies for treatment programs that also benefit its ‘drug company’ donors, the article also zeroed in on NAMI. That’s right! The Inquirer reported that NAMI did not disclose that Lilly marketing manager Gerald Radke briefly ran its entire operation. Although patients seldom know it, the Philadelphia Inquirer. 2006 investigative article on the relationships between patient advocacy groups and pharmaceutical companies stated that, quite a few patient groups and drug companies maintain close, multimilliondollar relationships while disclosing limited or no details about the ties.

Lilly donated at least $ 3 million to NAMI.

For its part, NAMI promotes the increased use of psychotropic drugs, lobbies against any cost saving restrictions on number of psychotropic drugs prescribed for one patient under Medicaid, and even lobbies for laws allowing mental patients to be forced to take antipsychotic drugs.

NAMI’s failure to inform its constituents about the danger these drugs pose for patients, and its continued aggressive promotion of these drugs despite the evidence, can be viewed as confirmation that NAMI is an extension of Lilly’s marketing department. I know that the drugs most often prescribed for involuntary patients Janssen’s Risperdal and Lilly’s Zyprexa cause debilitating, indeed, lethal effects. On December 18, 2003, The New York City Times exposed that NAMI had bused scores of protestors to a hearing in Frankfort, Kentucky, ok out full page ads in Kentucky newspapers, and sent angry faxes to state officials, all to protest a state panel proposal to exclude the antipsychotic drug Zyprexa from Medicaid’s list of preferred medications.